BioInquire

Simultaneous qual-quan workflows generate significantly more data than many conventional mass spec assays, posing a challenge for vendors of ensuring that their software offerings keep pace with the expanded capabilities of their hardware.

The separations products company plans to buy the mass spec analysis software maker for at least $3 million.

The deal, valued at more than $3 million, would provide NuSep with BioInquire's ProteoIQ software, which helps customers identify proteins separated by mass spec instruments.

The firm will use the funding to develop its proteomics software platform.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.